SCHEMBL2856058

SCHEMBL2856058

COC(=O)COc1ccc(CN)cc1C(=O)OC

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
HTT P42858 2/20 0.48
LOXL2 Q9Y4K0 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
CYP1A2 P05177 1/20 0.47
KDM4E B2RXH2 3/20 0.47
MAPT P10636 3/20 0.47
HPGD P15428 2/20 0.47
GAA P10253 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
HSD17B10 Q99714 1/20 0.47
LMNA P02545 2/20 0.44
APP P05067 1/20 0.41
PTGDR Q13258 1/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL2853897 0.96 ALDH1A1 (0.45) ALDH1A1HTTLOXL2SMN1; SMN2MEN1
SCHEMBL30362267 0.83 HPGD (0.54) ALDH1A1HTTLOXL2SMN1; SMN2KDM4E
SCHEMBL1361424 0.83 HPGD (0.54) ALDH1A1HTTLOXL2SMN1; SMN2KDM4E
SCHEMBL3783005 0.81 MEN1 (0.52) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL25337618 0.79 PTGDR (0.56) ALDH1A1MEN1KMT2ACYP1A2MAPT
SCHEMBL8191837 0.79 KMT2A (0.52) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL25337583 0.79 ALDH1A1 (0.54) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL2031300 0.78 ALDH1A1 (0.56) ALDH1A1SMN1; SMN2MEN1KMT2ACYP1A2
SCHEMBL11271034 0.78 PTGDR2 (0.48) ALDH1A1HTTSMN1; SMN2MEN1KMT2A
SCHEMBL25336183 0.76 CFTR (0.54) ALDH1A1HTTMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1654247-B1 ALKYNYL ARYL CARBOXAMIDES MERCK SERONO SA (CH) 2010-01-20 EP disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-7589232-B2 Alkynyl aryl carboxamides LABORATORIES SERONO S.A. (CH) 2009-09-15 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
US-20070105913-A1 Alkynyl aryl carboxamides APPLIED RESEARCH SYSTEMS ARS HOLDINGS N.V. (NL) 2007-05-10 US disclosed
EP-1668004-A1 BENZOXAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 EP disclosed
EP-1654247-A1 ALKYNYL ARYL CARBOXAMIDES Applied Research Systems ARS Holding N.V. (AN) 2006-05-10 EP disclosed
WO-2005026159-A1 BENZOXAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 WO disclosed
WO-2005012280-A1 ALKYNYL ARYL CARBOXAMIDES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-02-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070105913-A1 Alkynyl aryl carboxamides ECHS1, IRS1, HCCS ALDH1A1 1454/4885HTT 1134/4885LOXL2 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.